Journal of Investigative Medicine High Impact Case Reports
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.7 | Q3 | 36.3% | 0.274 | Q3 | 40.2% |
| 2024 | 0.8 | Q3 | 42.6% | 0.317 | Q3 | 47.4% |
| 2023 | 0.9 | Q3 | 49.0% | 0.294 | Q3 | 48.2% |
| 2022 | 1.2 | 53.7% | 0.307 | Q2 | 51.4% | |
| 2021 | — | 52.3% | 0.296 | Q3 | 51.0% | |
| 2020 | — | — | 0.247 | Q3 | 43.7% | |
| 2019 | — | — | 0.262 | Q3 | 47.9% | |
| 2018 | — | — | 0.531 | Q2 | 67.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2324-7096
country
GBcoverage
2013-2026